Pemetrexed Market
According to Intent Market Research, the Pemetrexed Market is expected to grow from USD 2.5 billion in 2024-e at a CAGR of 8.5% to touch USD 4.1 billion by 2030. The Pemetrexed Market is dominated by key players such as, Teva Pharmaceutical Industries, Eli Lilly and Company, Sandoz (Novartis), Cipla... Read More